ES2057579T3 - Peptidos e1 y c de rubeola. - Google Patents

Peptidos e1 y c de rubeola.

Info

Publication number
ES2057579T3
ES2057579T3 ES90911900T ES90911900T ES2057579T3 ES 2057579 T3 ES2057579 T3 ES 2057579T3 ES 90911900 T ES90911900 T ES 90911900T ES 90911900 T ES90911900 T ES 90911900T ES 2057579 T3 ES2057579 T3 ES 2057579T3
Authority
ES
Spain
Prior art keywords
peptides
rubella
useful
rubeola
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90911900T
Other languages
English (en)
Inventor
Martial Lacroix
Maan Zrein
Gervais Dionne
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Adaltis US Inc
Original Assignee
Biochem Immunosystems US Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biochem Immunosystems US Inc filed Critical Biochem Immunosystems US Inc
Application granted granted Critical
Publication of ES2057579T3 publication Critical patent/ES2057579T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/36011—Togaviridae
    • C12N2770/36211—Rubivirus, e.g. rubella virus
    • C12N2770/36222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

PEPTIDOS LINEALES Y CICLICOS DE LA PROTEINA E1 Y C DEL VIRUS DE LA RUBEOLA. ESTOS PEPTIDOS Y ANALOGOS, SUS MEZCLAS Y COMBINACIONES SON UTILES PARA DETECTAR Y CUANTIFICAR ANTICUERPOS CULTIVADOS CONTRA EL VIRUS DE LA RUBEOLA. SON TAMBIEN UTILES EN CULTIVAR ANTICUERPOS DEL VIRUS DE LA RUBEOLA PARA UTILIZAR EN LA DIAGNOSIS Y PROTECCION CONTRA LAS INFECCIONES VIRALES DE LA RUBEOLA.
ES90911900T 1989-08-23 1990-08-17 Peptidos e1 y c de rubeola. Expired - Lifetime ES2057579T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/397,767 US5164481A (en) 1989-08-23 1989-08-23 Peptides and analogues and mixtures thereof for detecting and eliciting antibodies to rubella virus

Publications (1)

Publication Number Publication Date
ES2057579T3 true ES2057579T3 (es) 1994-10-16

Family

ID=23572541

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90911900T Expired - Lifetime ES2057579T3 (es) 1989-08-23 1990-08-17 Peptidos e1 y c de rubeola.

Country Status (12)

Country Link
US (2) US5164481A (es)
EP (1) EP0491713B1 (es)
JP (1) JP3317967B2 (es)
AT (1) ATE109158T1 (es)
AU (1) AU646641B2 (es)
CA (1) CA2065022C (es)
DE (1) DE69011122T2 (es)
DK (1) DK0491713T3 (es)
ES (1) ES2057579T3 (es)
HU (1) HUT60508A (es)
OA (1) OA09653A (es)
WO (1) WO1991002748A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5427792A (en) * 1989-08-23 1995-06-27 Biochem Immunosystems, Inc. Peptides, analogues and mixtures thereof for detecting and eliciting antibodies to the E1 and E2 protein of rubella virus
GB9201139D0 (en) * 1992-01-20 1992-03-11 Connaught Lab Synthetic peptides for a rubella vaccine
US6008058A (en) * 1993-06-18 1999-12-28 University Of Louisville Cyclic peptide mixtures via side chain or backbone attachment and solid phase synthesis
US5510264A (en) * 1993-09-28 1996-04-23 Insight Biotech Inc. Antibodies which bind meningitis related homologous antigenic sequences
US6180758B1 (en) * 1994-10-06 2001-01-30 Connaught Laboratories Limited Synthetic peptides for rubella vaccine
EP1135684B1 (en) 1998-12-01 2006-01-11 Viral Antigens, Inc. IMPROVED SPECIFICITY IN THE DETECTION OF ANTI-RUBELLA IgM ANTIBODIES
JP2010519916A (ja) * 2007-03-06 2010-06-10 リボバックス バイオテクノロジーズ ソシエテ アノニム 風疹ウイルスに特異的な抗体
CN101402960B (zh) * 2008-08-13 2011-05-11 吴丽霞 一种重组风疹病毒e1蛋白及其应用
US8734798B2 (en) * 2009-10-27 2014-05-27 Ucb Pharma S.A. Function modifying NAv 1.7 antibodies

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU592142B2 (en) * 1985-11-25 1990-01-04 Cytogen Corporation Modified viral glycoproteins, diagnostic and therapeutic uses therefore
GB2206587A (en) * 1987-07-08 1989-01-11 London Biotechnology Ltd Rubella e1 glycoprotein antigens

Also Published As

Publication number Publication date
WO1991002748A1 (en) 1991-03-07
AU646641B2 (en) 1994-03-03
US5298596A (en) 1994-03-29
JP3317967B2 (ja) 2002-08-26
US5164481A (en) 1992-11-17
ATE109158T1 (de) 1994-08-15
EP0491713A1 (en) 1992-07-01
DK0491713T3 (da) 1994-09-26
AU6151790A (en) 1991-04-03
OA09653A (en) 1993-05-15
CA2065022A1 (en) 1991-02-24
HU9200583D0 (en) 1992-05-28
JPH04507409A (ja) 1992-12-24
DE69011122D1 (de) 1994-09-01
HUT60508A (en) 1992-09-28
CA2065022C (en) 2001-11-20
DE69011122T2 (de) 1994-11-10
EP0491713B1 (en) 1994-07-27

Similar Documents

Publication Publication Date Title
UA130113C2 (uk) Мутеїн інтерлейкіну-21
EA200401405A1 (ru) Модифицированный осповакцинный вирус анкара для вакцинации новорожденных
ES2138784T3 (es) Antigenos sinteticos para la deteccion de anticuerpos contra el virus de la hepatitis c.
ES2062971T3 (es) Peptidos de la cubierta de htlv iii.
DK614987A (da) Syntetiske htlv-iii peptider, praeparater og anvendelser deraf
DE68927348D1 (de) Künstlicher impfstoff gegen aids-virus
ES2078255T3 (es) Regiones inmunogenas en la proteina e-7 del papilomavirus humano tipo 16.
ES8500997A1 (es) Un metodo para producir un peptido.
ES2144399T3 (es) Clonado del adn de virus de anemia de los pollos.
ES2057579T3 (es) Peptidos e1 y c de rubeola.
DK0437604T3 (da) Rekombinant poxvirus- og streptokok M-proteinvaccine
ATE70280T1 (de) Charakteristische polypeptide und antikoerper vom papillomavirus, diagnostische verfahren und dieselben verwendende impfungen.
ITMI913092A1 (it) Vaccino di poxvirus ricombinante del virus del morbillo
NO20005608L (no) Strukturelle proteiner fra fisk-pankreatisk-sykdomsvirus og anvendelser derav
IT1249684B (it) Epitopi della proteina env del virus dell'epatite c.
ES2145055T3 (es) Peptidos, sus analogos y mezclas para detectar y producir anticuerpos de las proteinas e1 y e2 del virus de la rubeola.
ES2061566T3 (es) Anticuerpos monoclonales contra la proteina e7 del papilomavirus humano tipo 16, procedimiento para su preparacion, asi como su empleo.
ES2149822T3 (es) Peptidos inmunorreactivos procedentes del virus de epstein-barr.
DK1537204T3 (da) Granzym B som HSP70/HSP70-peptidafhængig udløser af programmeret celledød hos tumorceller
ES2095899T3 (es) Peptidos de la proteina gag de vih, su preparacion y uso.
ES2071038T3 (es) Peptidos asociados al hiv.
ES2194008T3 (es) Proteina p100 del virus del herpes humano tipo 6, las correspondientes secuencias de adn, su preparacion y uso.
NO881661D0 (no) Humane rhinoviruspeptider.
ES2126598T3 (es) Anticuerpos monoclonales que se fijan sobre las proteinas ns5 supuestas del virus de la hepatitis c, y procedimientos de utilizacion de estos anticuerpos.
ES2042481T1 (es) Peptidos sinteticos que derivan del antigeno hbc del virus de la hepatitis b.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 491713

Country of ref document: ES